Seoul National University

Researchers

• ASAesun Shin

Running trials

• Not yet recruiting

  Minimally Invasive Radical Hysterectomy Using Endoscopic Stapler in Stage IB2 or IIA1 Cervical Cancer

  NCT07256977· Seoul National University Hospital· Source

• Not yet recruiting

  Phase 2 Trial to Evaluate the Efficacy, Safety of Allogeneic Mitochondria (PN-101) in Patients With Refractory Polymyositis or Dermatomyositis

  NCT07122648· Phase 2· Paean Biotechnology Inc.· Source

• Enrolling by invitation

  A Study of KITE-363 in Participants With Refractory Autoimmune Diseases

  NCT07038447· Phase 1· Kite, A Gilead Company· Source

• Active, not recruiting

  Impact of Concomitant Use of Steroids and Immune-Checkpoint Inhibitors on Survival Outcomes in NSCLC Patients

  NCT06751108· Seoul National University· Source

• Active, not recruiting

  Clinical Study to Evaluate Efficacy and Safety of ANT-301 in Patients With Knee Osteoarthritis in Grade III/IV by K/L

  NCT06539429· Phase 1· Anterogen Co., Ltd.· Source

• Recruiting

  Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

  NCT06500273· Phase 2· Allogene Therapeutics· Source

• Active, not recruiting

  A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)

  NCT06023862· Phase 2· Yonsei University· Source

• Recruiting

  A Phase 1, SAD and MAD Study to Evaluate the Safety and Tolerability of FB418

  NCT05995782· Phase 1· 1ST Biotherapeutics, Inc.· Source

• Active, not recruiting

  An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma

  NCT05876754· Phase 3· Servier Affaires Médicales· Source

• Recruiting

  NeoFOL-R Trial (Perioperative Versus Adjuvnat FOLFIRINOX in Resectable Pancreatic Cancer)

  NCT05529940· Phase 3· Seoul National University Hospital· Source

• Active, not recruiting

  AMP SCZ® Observational Study: PREDICT-DPACC

  NCT05905003· Brigham and Women's Hospital· Source

• Active, not recruiting

  A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)

  NCT02912949· Phase 2· Partner Therapeutics, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Dermatomyositis and polymyositis (myositis)2 recruiting
• ALS (motor neurone disease)1 recruiting
• Cervical cancer1 recruiting
• Diffuse large B-cell lymphoma1 recruiting
• Lupus (SLE)1 recruiting
• Pancreatic cancer1 recruiting
• Parkinson disease1 recruiting
• Systemic sclerosis (scleroderma)1 recruiting

Closed trials

• Completed

  Effects of Transcutaneous Auricular Vagus Nerve Stimulation on Appetite

  NCT07444177· Seoul National University Hospital· Source

• Terminated

  (SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC

  NCT04862780· Phase 1· Blueprint Medicines Corporation· Source

• Completed

  TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers

  NCT04306900· Phase 1· Trishula Therapeutics, Inc.· Source

• Terminated

  Focused Ultrasound for the Treatment of Pancreatic Cancer - an International Registry

  NCT03724435· Focused Ultrasound Foundation· Source

• Terminated

  RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer

  NCT03894215· Phase 2· Agenus Inc.· Source

• Completed

  Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination With Pembrolizumab

  NCT03674567· Phase 1/2· RAPT Therapeutics, Inc., a member of the GSK plc group of companies· Source

• Completed

  ABO- or HLA- Incompatible LDKT Compared to Waitlist/DDKT in Elderly Patients

  NCT07436338· Seoul National University Hospital· Source

• Completed

  Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia

  NCT01064440· Phase 2· Helixmith Co., Ltd.· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Stroke257 works · 0 trials
• Liver and biliary tract cancer197 works · 1 trial
• Obesity177 works · 1 trial
• Alzheimer disease174 works · 0 trials
• Lung cancer168 works · 5 trials
• Type 2 diabetes125 works · 0 trials
• Gastric and oesophageal cancer124 works · 0 trials
• Heart failure110 works · 0 trials
• Chronic kidney disease107 works · 1 trial
• Colorectal cancer104 works · 1 trial
• Atrial fibrillation102 works · 0 trials
• Parkinson disease90 works · 1 trial
• Pancreatic cancer62 works · 4 trials
• Mild cognitive impairment60 works · 0 trials
• Asthma58 works · 0 trials
• Fatty liver disease (MASLD/MASH)57 works · 0 trials
• Osteoarthritis51 works · 1 trial
• Schizophrenia47 works · 1 trial
• Ovarian cancer47 works · 1 trial
• Glioblastoma44 works · 0 trials
• Osteoporosis44 works · 0 trials
• Tuberculosis43 works · 0 trials
• COPD42 works · 0 trials
• Thyroid cancer42 works · 0 trials
• Glaucoma41 works · 0 trials
• Coronary artery disease39 works · 0 trials
• Bladder cancer39 works · 2 trials
• Triple-negative breast cancer39 works · 0 trials
• Insomnia37 works · 0 trials
• Melanoma37 works · 0 trials